Skip to content
healthcare.dev
Get a free key

Deconex IR

NDC 50991-736, Guaifenesin and Phenylephrine HCl, tablet, from Poly Pharmaceuticals, Inc..

Product NDC
50991-736
Status
Listed
Labeler
Poly Pharmaceuticals, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M012
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50991-736 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GUAIFENESIN385 mg/1
  • PHENYLEPHRINE HYDROCHLORIDE10 mg/1

Pharmacologic classes

Adrenergic alpha1-Agonists [MoA]; Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]; alpha-1 Adrenergic Agonist [EPC]

Package NDCNDC-11Package
50991-736-025099107360212 BLISTER PACK in 1 CARTON (50991-736-02) / 2 TABLET in 1 BLISTER PACK
50991-736-90509910736901 BOTTLE in 1 CARTON (50991-736-90) / 90 TABLET in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 50991-736 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50991-736 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50991-736. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.